Denise Serra

2.0k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Denise Serra is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Denise Serra has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Denise Serra's work include Diabetes Treatment and Management (8 papers), Peptidase Inhibition and Analysis (6 papers) and Hepatitis C virus research (3 papers). Denise Serra is often cited by papers focused on Diabetes Treatment and Management (8 papers), Peptidase Inhibition and Analysis (6 papers) and Hepatitis C virus research (3 papers). Denise Serra collaborates with scholars based in United States, Switzerland and Denmark. Denise Serra's co-authors include Prisca Liberali, Ilya Lukonin, Michael Stadler, Ludivine Challet Meylan, Urs Mayr, James E. Foley, Yibin Wang, Guglielmo Roma, Annick Waldt and Markus Rempfler and has published in prestigious journals such as Nature, Gastroenterology and Development.

In The Last Decade

Denise Serra

21 papers receiving 1.4k citations

Hit Papers

Self-organization and symmetry breaking in intestinal org... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Serra United States 16 652 463 458 314 217 22 1.4k
Ulrich Marti Switzerland 18 603 0.9× 248 0.5× 334 0.7× 242 0.8× 109 0.5× 41 1.4k
Afşar Barlas United States 18 1.2k 1.8× 115 0.2× 410 0.9× 209 0.7× 181 0.8× 35 2.0k
Joo‐ri Kim‐Kaneyama Japan 23 854 1.3× 221 0.5× 184 0.4× 287 0.9× 49 0.2× 44 1.8k
Anthony Valentijn United Kingdom 24 1.0k 1.5× 286 0.6× 362 0.8× 78 0.2× 31 0.1× 33 1.9k
Tin Htwe Thin United States 18 906 1.4× 403 0.9× 417 0.9× 92 0.3× 47 0.2× 25 1.7k
Kristin F. Wilson United States 21 1.3k 1.9× 398 0.9× 199 0.4× 58 0.2× 70 0.3× 30 1.8k
Brian Hampton United States 20 1.0k 1.6× 539 1.2× 253 0.6× 160 0.5× 37 0.2× 36 1.7k
Douglas W. Burton United States 23 810 1.2× 189 0.4× 563 1.2× 135 0.4× 30 0.1× 52 1.6k
Amber Giles United States 16 673 1.0× 81 0.2× 817 1.8× 120 0.4× 113 0.5× 26 2.1k
John Doukas United States 20 836 1.3× 76 0.2× 291 0.6× 203 0.6× 40 0.2× 35 1.9k

Countries citing papers authored by Denise Serra

Since Specialization
Citations

This map shows the geographic impact of Denise Serra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Serra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Serra more than expected).

Fields of papers citing papers by Denise Serra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Serra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Serra. The network helps show where Denise Serra may publish in the future.

Co-authorship network of co-authors of Denise Serra

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Serra. A scholar is included among the top collaborators of Denise Serra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Serra. Denise Serra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukonin, Ilya, Denise Serra, Ludivine Challet Meylan, et al.. (2020). Phenotypic landscape of intestinal organoid regeneration. Nature. 586(7828). 275–280. 180 indexed citations
2.
Serra, Denise, Urs Mayr, Andrea Boni, et al.. (2019). Self-organization and symmetry breaking in intestinal organoid development. Nature. 569(7754). 66–72. 372 indexed citations breakdown →
3.
Mayr, Urs, Denise Serra, & Prisca Liberali. (2019). Exploring single cells in space and time during tissue development, homeostasis and regeneration. Development. 146(12). 40 indexed citations
4.
Hannesdóttir, Kristín, Oleksandr Sverdlov, Jelena Curcic, et al.. (2018). P4‐339: THE MEDIA STUDY: A NOVEL METHOD FOR EVALUATING DIGITAL ENDPOINTS IN ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 14(7S_Part_30).
5.
Engelholm, Lars H., Anjum Riaz, Denise Serra, et al.. (2017). CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1–Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma. Gastroenterology. 153(6). 1662–1673.e10. 75 indexed citations
6.
Grosskreutz, Cynthia L., Hans Hockey, Denise Serra, & Thaddeus P. Dryja. (2015). Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab. Cornea. 34(12). 1551–1556. 18 indexed citations
7.
Sunkara, Gangadhar, Xuemin Jiang, Christine Reynolds, et al.. (2014). Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects. Clinical Pharmacology in Drug Development. 3(6). 487–492. 8 indexed citations
8.
Serra, Denise, et al.. (2011). Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers. Current Medical Research and Opinion. 27(7). 1453–1463. 15 indexed citations
10.
Läwitz, E., Roman Rouzier, Menghao Huang, et al.. (2009). 1045 SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON α2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS. Journal of Hepatology. 50. S379–S379. 15 indexed citations
11.
Vella, Adrian, Gerlies Bock, Paula D. Giesler, et al.. (2008). The effect of dipeptidyl peptidase‐4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double‐blind, placebo‐controlled crossover study. Clinical Endocrinology. 69(5). 737–744. 50 indexed citations
12.
Serra, Denise, Julie Bullock, S. Schwartz, et al.. (2008). Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes. International Journal of Clinical Pharmacology and Therapeutics. 46(7). 349–364. 25 indexed citations
13.
Man, Chiara Dalla, Gerlies Bock, Paula D. Giesler, et al.. (2008). Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes. Diabetes Care. 32(1). 14–18. 51 indexed citations
14.
He, Yanling, Denise Serra, Yibin Wang, et al.. (2007). Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus. Clinical Pharmacokinetics. 46(7). 577–588. 88 indexed citations
15.
Azuma, Koichiro, Žofia Rádiková, Juliet Mancino, et al.. (2007). Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 93(2). 459–464. 98 indexed citations
16.
Vella, Adrian, Gerlies Bock, Paula D. Giesler, et al.. (2007). Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 Diabetes. Diabetes. 56(5). 1475–1480. 162 indexed citations
17.
Schmouder, Robert, Denise Serra, Yibin Wang, et al.. (2006). FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects. The Journal of Clinical Pharmacology. 46(8). 895–904. 94 indexed citations
18.
Serra, Denise, Melton B. Affrime, Martin P. Bedigian, et al.. (2005). QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M3 Selective Receptor Antagonist for the Treatment of Overactive Bladder. The Journal of Clinical Pharmacology. 45(9). 1038–1047. 48 indexed citations
19.
Kovarik, John M., et al.. (2005). FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment. The Journal of Clinical Pharmacology. 45(4). 446–452. 17 indexed citations
20.
He, Yanling, et al.. (2005). Pharmacokinetics and pharmacodynamics of the DPP-4 inhibitor, LAF237, in patients with type 2 diabetes. Clinical Pharmacology & Therapeutics. 77(2). P56–P56. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026